GLP2-TZ 10-20MG

This compound is a synthetic dual-acting peptide that functions as an agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual incretin mechanism has been a significant area of metabolic research, with published studies investigating its effects on insulin sensitivity, pancreatic beta-cell function, lipid metabolism, and body composition. Its unique pharmacological profile has made it a subject of interest in research exploring the synergistic effects of combined incretin receptor activation. This lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.